Home / Inspections / 1297784

1297784

Takeda Pharmaceutical Company d.b.a. BioLife Plasma Services LP — FEI 3014948212

Inspection Details

Classification: No Action Indicated (NAI) (NAI)
End Date: December 5, 2025
Fiscal Year: 2026
Product Type: Biologics
Project Area: Blood and Blood Products
Location: Kansas City, MO (United States)